AXTI three-lens brief
Evidence-based stock research on AXTI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 19.49% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price up 19.49% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 39.0pp over 30 days.
- P/E of 96 — priced for high growth; little margin of safety.
- Analyst mean target $91.50 — 95% above current (6 analysts).
AXTI closed at $46.97 (+19.49%) as of 2026-11-12. Market cap: $3.08B. P/E (trailing) 95.9. Price is below the 50-day MA and below the 200-day MA. Positives: price up 19.49% in the last session — a material single-day move.; analyst mean target $91.50 — 95% above current (6 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 39.0pp over 30 days.. Last quarter: Revenue $73.41M, net income $25.72M.
Why three lenses on AXTI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AXTI across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AXTI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AXTI brief"></iframe>